先进的乳腺癌免疫疗法:对NK细胞进行表面修饰以嵌入抗体-药物联合体
Su Yeon Lim1, Seungmin Han2, Yihyeon Kim1
1Department of Smart Health Science and Technology, Kangwon National University, Chuncheon 24341, Republic of Korea.
概括
一种全新的全局表面工程NK (USE-NK) 细胞平台,通过在没有遗传修饰的情况下通过附加抗体或ADC来实现向化疗免疫疗法. 这增强了癌细胞向和细胞毒性,为癌症治疗提供了灵活的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 结合抗体药物合物 (ADC) 与免疫疗法,显示出癌症治疗的前景.
- 有效地整合化疗和免疫疗法仍然是瘤学中的一个重大挑战.
研究的目的:
- 引入一个通用的表面工程NK (USE-NK) 细胞平台,用于向化疗免疫疗法.
- 为了使免疫细胞能够快速修改以进行自发抗体或ADC结合.
主要方法:
- 利用复合融合蛋白 (C3) 和基于聚合脂的结合策略,将抗体附在NK细胞表面上.
- 采用非遗传修饰来保持本地NK细胞的功能.
- 结合的USE-NK细胞与特拉斯图祖马布 (TZ) 和特拉斯图祖马布-emtansine (T-DM1) 在体外和体内研究.
主要成果:
- 与TZ或T-DM1结合的USE-NK细胞与单个治疗相比,表现出优异的HER2阳性癌细胞识别和细胞毒性.
- 这种增强是由于向药物输送,改善NK细胞向瘤的动员,以及直接NK细胞细胞毒性.
- 该平台显示增强瘤向性,并最大限度地降低了非向性毒性.
结论:
- USE-NK平台提供了一种快速,非侵入性和可逆的化学免疫疗法方法.
- 这种可适应的技术扩展到其他免疫细胞疗法,如CAR-T和CAR-NK细胞.
- 该平台支持多抗原向,以对抗瘤异质性,将其定位为个性化和现成的癌症免疫疗法.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.7K
13:59High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
Published on: August 18, 2023
2.2K
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cytotoxic T Cells-mediated Immune Response
2.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K
